Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 112,512 | 80,459 | 49,988 | 23,465 | 106,011 |
| Depreciation Amortization | 8,559 | 2,270 | 1,499 | 1,937 | 2,237 |
| Income taxes - deferred | 4,346 | 2,047 | -2,061 | -5,360 | 14,089 |
| Accounts receivable | -1,427 | -310 | -1,422 | 3,998 | -6,270 |
| Accounts payable and accrued liabilities | -3,597 | -3,961 | -1,304 | -3,493 | 3,161 |
| Other Working Capital | -466 | -2,237 | -3,305 | -4,721 | -5,357 |
| Other Operating Activity | 47,965 | 40,197 | 26,366 | 9,596 | 38,099 |
| Operating Cash Flow | $167,892 | $118,465 | $69,761 | $25,422 | $151,970 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 136,595 | -312,805 | -223,268 | -3,158 | 302,089 |
| PPE Investments | -469 | -404 | -245 | -126 | -1,238 |
| Purchase Of Investment | N/A | 308,864 | 244,971 | N/A | -420,114 |
| Investing Cash Flow | $136,126 | $-4,345 | $21,458 | $-3,284 | $-119,263 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,229 | 13,182 | 8,786 | 4,038 | 23,226 |
| Common Stock Repurchased | -295,985 | -88,485 | -62,711 | -33,541 | -9,945 |
| Other Financing Activity | -22,835 | -20,319 | -18,054 | -16,444 | -1,067 |
| Financing Cash Flow | $-302,591 | $-95,622 | $-71,979 | $-45,947 | $12,214 |
| Beginning Cash Position | 76,190 | 76,190 | 76,190 | 76,190 | 31,269 |
| End Cash Position | 77,617 | 94,688 | 95,430 | 52,381 | 76,190 |
| Net Cash Flow | $1,427 | $18,498 | $19,240 | $-23,809 | $44,921 |
| Free Cash Flow | |||||
| Operating Cash Flow | 167,892 | 118,465 | 69,761 | 25,422 | 151,970 |
| Capital Expenditure | -469 | -404 | -245 | -126 | -1,238 |
| Free Cash Flow | 167,423 | 118,061 | 69,516 | 25,296 | 150,732 |